New and costly methods provide opportunities for health gain. But they also present challenges related to prioritization and resource allocation.
This information may be inaccurate due to changes in regulations from January 1 2018. Updated information will be published in English shortly. Please send an email to email@example.com if you have any questions.
To deal with the above, a national system for the assessment of new and costly methods in the specialist health service has now been introduced.
Read more about
the national system for the introduction of new health technologies within the specialist health service on the Norwegian Directorate of Health’s website.
The national system for the introduction of new health technologies within the specialist health service involves the use of single technology assessments when introducing medical devices, diagnostic measures, procedures and pharmaceuticals.
Two STA templates have been developed:
NOMA offers guidance that can be used to identify and discuss ambiguities that may arise in the process and preparation of documentation for the STA of a given drug.
A guidance for these meetings is prepared.